These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9722128)

  • 41. Fluoxetine for premenstrual dysphoria.
    Edbril SD
    N Engl J Med; 1995 Oct; 333(17):1152-3. PubMed ID: 7565961
    [No Abstract]   [Full Text] [Related]  

  • 42. Psychotropic medications and other non-hormonal treatments for premenstrual disorders.
    Pearlstein T
    Menopause Int; 2012 Jun; 18(2):60-4. PubMed ID: 22611223
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sertraline and alprazolam in the treatment of panic desorder.
    Fiseković S; Loga-Zec S
    Bosn J Basic Med Sci; 2005 May; 5(2):78-81. PubMed ID: 16053461
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of premenstrual disorders.
    Kroll R; Rapkin AJ
    J Reprod Med; 2006 Apr; 51(4 Suppl):359-70. PubMed ID: 16734319
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Controlled trial of pyridoxine in the premenstrual syndrome.
    Williams MJ; Harris RI; Dean BC
    J Int Med Res; 1985; 13(3):174-9. PubMed ID: 3891456
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fluoxetine versus Vitex agnus castus extract in the treatment of premenstrual dysphoric disorder.
    Atmaca M; Kumru S; Tezcan E
    Hum Psychopharmacol; 2003 Apr; 18(3):191-5. PubMed ID: 12672170
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The efficacy of Hypericum perforatum (St John's wort) for the treatment of premenstrual syndrome: a randomized, double-blind, placebo-controlled trial.
    Canning S; Waterman M; Orsi N; Ayres J; Simpson N; Dye L
    CNS Drugs; 2010 Mar; 24(3):207-25. PubMed ID: 20155996
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictors of response to sertraline treatment of severe premenstrual syndromes.
    Freeman EW; Sondheimer SJ; Polansky M; Garcia-Espagna B
    J Clin Psychiatry; 2000 Aug; 61(8):579-84. PubMed ID: 10982201
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Medical management of premenstrual dysphoric disorder.
    Yonkers KA
    J Gend Specif Med; 1999; 2(3):55-60. PubMed ID: 11252853
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial.
    Freeman EW; Rickels K; Sondheimer SJ; Polansky M
    Arch Gen Psychiatry; 1999 Oct; 56(10):932-9. PubMed ID: 10530636
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review.
    Wyatt KM; Dimmock PW; Jones PW; Shaughn O'Brien PM
    BMJ; 1999 May; 318(7195):1375-81. PubMed ID: 10334745
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Premenstrual syndrome therapy.
    Johnson SR
    Clin Obstet Gynecol; 1998 Jun; 41(2):405-21. PubMed ID: 9646973
    [No Abstract]   [Full Text] [Related]  

  • 53. No effect of vitamin B-6 against premenstrual tension. A controlled clinical study.
    Hagen I; Nesheim BI; Tuntland T
    Acta Obstet Gynecol Scand; 1985; 64(8):667-70. PubMed ID: 3914180
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Beyond premenstrual syndrome.
    Gupta S
    Time; 2002 Jun; 159(22):83. PubMed ID: 12066466
    [No Abstract]   [Full Text] [Related]  

  • 55. Management strategies for PMS/PMDD.
    Yonkers KA
    J Fam Pract; 2004 Sep; Suppl():S15-20. PubMed ID: 15508358
    [No Abstract]   [Full Text] [Related]  

  • 56. Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled study.
    Pollack MH; Simon NM; Zalta AK; Worthington JJ; Hoge EA; Mick E; Kinrys G; Oppenheimer J
    Biol Psychiatry; 2006 Feb; 59(3):211-5. PubMed ID: 16139813
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Old drug, new label.
    Harv Ment Health Lett; 2000 Nov; 17(5):5-6. PubMed ID: 11063540
    [No Abstract]   [Full Text] [Related]  

  • 58. Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study.
    Jermain DM; Preece CK; Sykes RL; Kuehl TJ; Sulak PJ
    Arch Fam Med; 1999; 8(4):328-32. PubMed ID: 10418540
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fluoxetine in the treatment of premenstrual dysphoria.
    Su TP; Schmidt PJ; Danaceau MA; Tobin MB; Rosenstein DL; Murphy DL; Rubinow DR
    Neuropsychopharmacology; 1997 May; 16(5):346-56. PubMed ID: 9109106
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The use of fluoxetine (Prozac) in premenstrual syndrome: is the incidence of sexual dysfunction and anorgasmia acceptable?
    Oláh KS
    J Obstet Gynaecol; 2002 Jan; 22(1):81-3. PubMed ID: 12521737
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.